To monitor the impact of AVP stimulation and Dyn2 inhibition on breast cancer cells invasion, transwell assay was performed after cells being treated with AVP, DYN+AVP, DYN+Wort, and AVP/Wort/DYN. The gene discussed is DNM2; the disease is breast cancer.